RGNX REGENXBIO Inc.
Nasdaq · SEC CIK 1590877 · EDGAR
- Bought, last 12 months
- $949.4K 1 purchases by 1 insiders
- Sold, last 12 months
- $1.28M 6 sales by 2 insiders
- Filings on record
- 138 since 2021-07-29, latest 2026-09-03 17:30
BoughtSold
Most active insiders, 12 months
| Insider | Title | Bought | Sold |
|---|---|---|---|
| Ciongoli Gregory Austin | Dir | $949.4K | — |
| PAKOLA STEVE | Chief Medical Off | — | $940.0K |
| Simpson Curran | CEO, Dir | — | $339.1K |
| Malzahn Craig | CTO | — | — |
| Bennett Jean | Dir | — | — |
| Chan Mitchell | CFO | — | — |
| Zachary Jennifer | Dir | — | — |
| Glucksmann Alexandra | Dir | — | — |
| Fox Allan M. | Dir | — | — |
| Mills Kenneth T. | Dir | — | — |
Transactions 180
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DT | 2024-03-18 | 2024-03-14 | RGNX | Mills Kenneth T. | Pres, CEO, Dir | M - OptEx | $3.76 | +15.0K | 423.0K | +4% | +$56.4K |
| DT | 2024-03-18 | 2024-03-14 | RGNX | Mills Kenneth T. | Pres, CEO, Dir | S - Sale+OE | $21.86 | -15.0K | 408.0K | -4% | -$327.9K |
| DT | 2024-03-07 | 2024-03-05 | RGNX | PAKOLA STEVE | Chief Medical Off | S - Sale+OE | $28.36 | -12.9K | 107.2K | -11% | -$365.2K |
| DT | 2024-03-07 | 2024-03-05 | RGNX | PAKOLA STEVE | Chief Medical Off | M - OptEx | $22.25 | +12.9K | 120.1K | +12% | +$286.5K |
| DT | 2024-02-16 | 2024-02-14 | RGNX | Mills Kenneth T. | Pres, CEO, Dir | M - OptEx | $3.76 | +15.0K | 423.0K | +4% | +$56.4K |
| DMT | 2024-02-16 | 2024-02-14 | RGNX | Mills Kenneth T. | Pres, CEO, Dir | S - Sale+OE | $16.75 | -15.0K | 418.4K | -3% | -$251.3K |
| DT | 2024-01-18 | 2024-01-16 | RGNX | Mills Kenneth T. | Pres, CEO, Dir | M - OptEx | $3.76 | +45.0K | 453.0K | +11% | +$169.2K |
| DT | 2024-01-18 | 2024-01-16 | RGNX | Mills Kenneth T. | Pres, CEO, Dir | S - Sale+OE | $15.18 | -45.0K | 408.0K | -10% | -$683.1K |
| D | 2024-01-04 | 2024-01-02 | RGNX | Mills Kenneth T. | Pres, CEO, Dir | F - Tax | $17.95 | -11.4K | 343.9K | -3% | -$203.9K |
| D | 2024-01-04 | 2024-01-02 | RGNX | Mills Kenneth T. | Pres, CEO, Dir | A - Grant | $0.00 | +64.1K | 408.0K | +19% | $0 |
| D | 2024-01-04 | 2024-01-02 | RGNX | Vasista Vittal | CFO | F - Tax | $17.95 | -4,534 | 210.5K | -2% | -$81.4K |
| D | 2024-01-04 | 2024-01-02 | RGNX | Vasista Vittal | CFO | A - Grant | $0.00 | +16.0K | 226.5K | +8% | $0 |
| DT | 2024-01-04 | 2024-01-02 | RGNX | PAKOLA STEVE | Chief Medical Off | F - Tax | $17.95 | -10.4K | 92.4K | -10% | -$186.4K |
| DT | 2024-01-04 | 2024-01-02 | RGNX | PAKOLA STEVE | Chief Medical Off | A - Grant | $0.00 | +32.1K | 124.4K | +35% | $0 |
| DT | 2024-01-04 | 2024-01-03 | RGNX | PAKOLA STEVE | Chief Medical Off | S - Sale | $17.39 | -17.2K | 107.2K | -14% | -$299.8K |
| D | 2024-01-04 | 2024-01-02 | RGNX | Christmas Patrick J. | CLO | A - Grant | $0.00 | +34.6K | 115.8K | +43% | $0 |
| D | 2024-01-04 | 2024-01-02 | RGNX | Christmas Patrick J. | CLO | F - Tax | $17.95 | -7,893 | 81.1K | -9% | -$141.7K |
| D | 2024-01-04 | 2024-01-02 | RGNX | Simpson Curran | Chief Oper, Tech. Off | A - Grant | $0.00 | +38.5K | 123.3K | +45% | $0 |
| D | 2024-01-04 | 2024-01-02 | RGNX | Simpson Curran | Chief Oper, Tech. Off | F - Tax | $17.95 | -8,120 | 84.9K | -9% | -$145.8K |
| DM | 2024-01-04 | 2022-06-30+ | RGNX | Danos Olivier | CSO | A - Grant | $0.8525 | +40.3K | 124.9K | +48% | +$34.4K |
| D | 2024-01-04 | 2024-01-02 | RGNX | Danos Olivier | CSO | F - Tax | $17.95 | -8,410 | 86.4K | -9% | -$151.0K |
| DMT | 2023-12-21 | 2023-12-19 | RGNX | Mills Kenneth T. | Pres, CEO, Dir | M - OptEx | $3.66 | +45.0K | 400.3K | +13% | +$164.8K |
| DT | 2023-12-21 | 2023-12-19 | RGNX | Mills Kenneth T. | Pres, CEO, Dir | S - Sale+OE | $19.69 | -45.0K | 355.3K | -11% | -$886.0K |
| D | 2023-06-06 | 2023-06-02 | RGNX | Zachary Jennifer | Dir | A - Grant | $0.00 | +3,486 | 9,506 | +58% | $0 |
| D | 2023-06-06 | 2023-06-02 | RGNX | Bennett Jean | Dir | A - Grant | $0.00 | +3,486 | 6,496 | +116% | $0 |
| D | 2023-06-06 | 2023-06-02 | RGNX | Fox Allan M. | Dir | A - Grant | $0.00 | +3,486 | 6,496 | +116% | $0 |
| D | 2023-06-06 | 2023-06-02 | RGNX | MIGAUSKY GEORGE V | Dir | A - Grant | $0.00 | +3,486 | 6,496 | +116% | $0 |
| D | 2023-06-06 | 2023-06-02 | RGNX | Glucksmann Alexandra | Dir | A - Grant | $0.00 | +3,486 | 6,496 | +116% | $0 |
| D | 2023-06-06 | 2023-06-02 | RGNX | Tasse Daniel | Dir | A - Grant | $0.00 | +3,486 | 6,496 | +116% | $0 |
| D | 2023-06-06 | 2023-06-02 | RGNX | KARABELAS ARGERIS N | Dir | A - Grant | $0.00 | +3,486 | 6,496 | +116% | $0 |
| D | 2023-06-06 | 2023-06-02 | RGNX | STUMP DAVID C | Dir | A - Grant | $0.00 | +3,486 | 6,496 | +116% | $0 |
| D | 2023-06-02 | 2023-05-31 | RGNX | Vasista Vittal | CFO | M - OptEx | $0.85 | +35.0K | 215.0K | +19% | +$29.8K |
| D | 2023-01-05 | 2023-01-03 | RGNX | Vasista Vittal | CFO | A - Grant | $0.00 | +46.2K | 180.0K | +35% | $0 |
| D | 2023-01-05 | 2023-01-03 | RGNX | Vasista Vittal | CFO | F - Tax | $22.68 | -1,333 | 133.8K | -1.0% | -$30.2K |
| D | 2023-01-05 | 2023-01-03 | RGNX | Christmas Patrick J. | CLO | A - Grant | $0.00 | +67.9K | 89.0K | +322% | $0 |
| D | 2023-01-05 | 2023-01-03 | RGNX | Christmas Patrick J. | CLO | F - Tax | $22.68 | -1,843 | 21.1K | -8% | -$41.8K |
| D | 2023-01-05 | 2023-01-03 | RGNX | Simpson Curran | Chief Oper, Tech. Off | F - Tax | $22.68 | -2,076 | 25.0K | -8% | -$47.1K |
| D | 2023-01-05 | 2023-01-03 | RGNX | Simpson Curran | Chief Oper, Tech. Off | A - Grant | $0.00 | +67.9K | 93.0K | +271% | $0 |
| D | 2023-01-05 | 2023-01-03 | RGNX | Mills Kenneth T. | Pres, CEO, Dir | A - Grant | $0.00 | +54.8K | 355.3K | +18% | $0 |
| D | 2023-01-05 | 2023-01-03 | RGNX | Mills Kenneth T. | Pres, CEO, Dir | F - Tax | $22.68 | -9,308 | 300.5K | -3% | -$211.1K |
| D | 2023-01-05 | 2023-01-03 | RGNX | PAKOLA STEVE | Chief Medical Off | F - Tax | $22.68 | -1,837 | 15.3K | -11% | -$41.7K |
| D | 2023-01-05 | 2023-01-03 | RGNX | PAKOLA STEVE | Chief Medical Off | A - Grant | $0.00 | +90.6K | 102.8K | +744% | $0 |
| D | 2023-01-05 | 2023-01-03 | RGNX | PAKOLA STEVE | Chief Medical Off | S - Sale | $22.17 | -3,138 | 12.2K | -20% | -$69.6K |
| D | 2023-01-05 | 2023-01-03 | RGNX | Danos Olivier | CSO | A - Grant | $0.00 | +65.9K | 93.0K | +244% | $0 |
| D | 2023-01-05 | 2023-01-03 | RGNX | Danos Olivier | CSO | F - Tax | $22.68 | -2,058 | 27.0K | -7% | -$46.7K |
| 2022-08-31 | 2022-08-30 | RGNX | Vasista Vittal | CFO | S - Sale | $30.24 | -2,400 | 135.2K | -2% | -$72.6K | |
| M | 2022-08-08 | 2022-08-04+ | RGNX | Vasista Vittal | CFO | S - Sale | $35.19 | -17.7K | 154.8K | -10% | -$622.1K |
| 2022-08-03 | 2022-08-01 | RGNX | Vasista Vittal | CFO | S - Sale | $31.26 | -2,400 | 155.2K | -2% | -$75.0K | |
| M | 2022-07-15 | 2022-07-13+ | RGNX | Vasista Vittal | CFO | S - Sale | $30.01 | -4,800 | 157.6K | -3% | -$144.0K |
| D | 2022-06-07 | 2022-06-03 | RGNX | Tasse Daniel | Dir | A - Grant | $0.00 | +3,010 | 3,010 | New | $0 |
| D | 2022-06-07 | 2022-06-03 | RGNX | KARABELAS ARGERIS N | Dir | A - Grant | $0.00 | +3,010 | 3,010 | New | $0 |
| D | 2022-06-07 | 2022-06-03 | RGNX | STUMP DAVID C | Dir | A - Grant | $0.00 | +3,010 | 3,010 | New | $0 |
| D | 2022-06-07 | 2022-06-03 | RGNX | Fox Allan M. | Dir | A - Grant | $0.00 | +3,010 | 3,010 | New | $0 |
| D | 2022-06-07 | 2022-06-03 | RGNX | Bennett Jean | Dir | A - Grant | $0.00 | +3,010 | 3,010 | New | $0 |
| D | 2022-06-07 | 2022-06-03 | RGNX | MIGAUSKY GEORGE V | Dir | A - Grant | $0.00 | +3,010 | 3,010 | New | $0 |
| D | 2022-06-07 | 2022-06-03 | RGNX | Zachary Jennifer | Dir | A - Grant | $0.00 | +6,020 | 6,020 | New | $0 |
| D | 2022-06-07 | 2022-06-03 | RGNX | Glucksmann Alexandra | Dir | A - Grant | $0.00 | +3,010 | 3,010 | New | $0 |
| D | 2022-01-24 | 2022-01-20 | RGNX | Vasista Vittal | CFO | M - OptEx | $0.85 | +29.9K | 162.4K | +23% | +$25.4K |
| D | 2022-01-04 | 2022-01-01 | RGNX | Mills Kenneth T. | Pres, CEO, Dir | F - Tax | $32.70 | -3,636 | 274.0K | -1% | -$118.9K |
| D | 2022-01-04 | 2022-01-03 | RGNX | Mills Kenneth T. | Pres, CEO, Dir | A - Grant | $0.00 | +35.8K | 309.8K | +13% | $0 |
| D | 2022-01-04 | 2022-01-01 | RGNX | PAKOLA STEVE | Chief Medical Off | F - Tax | $32.70 | -1,152 | 9,848 | -10% | -$37.7K |
| D | 2022-01-04 | 2022-01-03 | RGNX | PAKOLA STEVE | Chief Medical Off | A - Grant | $0.00 | +8,900 | 17.1K | +108% | $0 |
| D | 2022-01-04 | 2022-01-03 | RGNX | PAKOLA STEVE | Chief Medical Off | S - Sale | $33.75 | -1,598 | 8,250 | -16% | -$53.9K |
| D | 2022-01-04 | 2022-01-03 | RGNX | Vasista Vittal | CFO | A - Grant | $0.00 | +8,900 | 132.5K | +7% | $0 |
| D | 2022-01-04 | 2022-01-01 | RGNX | Christmas Patrick J. | CLO | F - Tax | $32.70 | -1,332 | 15.0K | -8% | -$43.6K |
| D | 2022-01-04 | 2022-01-03 | RGNX | Christmas Patrick J. | CLO | A - Grant | $0.00 | +7,900 | 22.9K | +53% | $0 |
| D | 2022-01-04 | 2022-01-01 | RGNX | Danos Olivier | CSO | F - Tax | $32.70 | -1,221 | 18.4K | -6% | -$39.9K |
| DM | 2022-01-04 | 2021-06-30+ | RGNX | Danos Olivier | CSO | A - Grant | $1.63 | +11.3K | 29.1K | +63% | +$18.4K |
| D | 2022-01-04 | 2022-01-01 | RGNX | Simpson Curran | Chief Oper, Tech. Off | F - Tax | $32.70 | -1,332 | 16.4K | -8% | -$43.6K |
| D | 2022-01-04 | 2022-01-03 | RGNX | Simpson Curran | Chief Oper, Tech. Off | A - Grant | $0.00 | +10.7K | 27.1K | +65% | $0 |
| MI | 2021-12-27 | 2021-12-22+ | RGNX | Fox Allan M. | Dir | S - Sale | $34.69 | -112.9K | 1.58M | -7% | -$3.92M |
| 2021-12-06 | 2021-12-02 | RGNX | Mills Kenneth T. | Pres, CEO, Dir | G - Gift | $0.00 | -3,300 | 277.7K | -1% | $0 | |
| D | 2021-11-10 | 2021-11-08 | RGNX | Mills Kenneth T. | Pres, CEO, Dir | M - OptEx | $3.76 | +1,500 | 282.5K | +0.5% | +$5,640 |
| D | 2021-11-10 | 2021-11-08 | RGNX | Mills Kenneth T. | Pres, CEO, Dir | S - Sale+OE | $40.00 | -1,500 | 281.0K | -0.5% | -$60.0K |
| D | 2021-09-29 | 2021-09-27 | RGNX | Mills Kenneth T. | Pres, CEO, Dir | M - OptEx | $3.76 | +1,500 | 282.5K | +0.5% | +$5,640 |
| D | 2021-09-29 | 2021-09-27 | RGNX | Mills Kenneth T. | Pres, CEO, Dir | S - Sale+OE | $42.19 | -1,500 | 281.0K | -0.5% | -$63.3K |
| I | 2021-09-21 | 2021-09-17 | RGNX | Fox Allan M. | Dir | S - Sale | $45.04 | -48.2K | 1.36M | -3% | -$2.17M |
| DM | 2021-09-15 | 2021-09-13+ | RGNX | Mills Kenneth T. | Pres, CEO, Dir | M - OptEx | $3.62 | +38.0K | 314.1K | +14% | +$137.5K |
| DM | 2021-09-15 | 2021-09-13+ | RGNX | Mills Kenneth T. | Pres, CEO, Dir | S - Sale+OE | $44.71 | -38.0K | 281.0K | -12% | -$1.70M |
| D | 2021-07-29 | 2021-07-27 | RGNX | Vasista Vittal | CFO | M - OptEx | $0.85 | +10.0K | 123.6K | +9% | +$8,500 |
Purchase Sale Sale after option exercise All abbreviations